Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$1.09B |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$497M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$462M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.14B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$834M |
| 3 |
DuPont de Nemours
DD
|
+$438M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$367M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.52% |
| 2 | Financials | 7.65% |
| 3 | Consumer Discretionary | 5.72% |
| 4 | Communication Services | 5.59% |
| 5 | Healthcare | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3451
Franklin Covey
FC
$242M
| $302K | ﹤0.01% |
10,656
+3,791
| +55% | +$99.1K |
|
3452
iShares Global Consumer Staples ETF
KXI
$1.07B
| $302K | ﹤0.01% |
5,200
| – | – |
|
3453
Cato Corp
CATO
$68.3M
| $301K | ﹤0.01% |
25,097
+2,693
| +12% | +$31.7K |
|
3454
Security National Financial
SNFCA
$244M
| $301K | ﹤0.01% |
43,252
+17,345
| +67% | +$121K |
|
3455
Spyre Therapeutics
SYRE
$8.54B
| $301K | ﹤0.01% |
1,518
+929
| +158% | +$178K |
|
|
HMTV
3456
DELISTED
Hemisphere Media Group, Inc.
HMTV
| $300K | ﹤0.01% |
25,850
+4,311
| +20% | +$49.4K |
|
3457
Cytosorbents Corp
CTSO
$22.7M
| $299K | ﹤0.01% |
34,344
+21,084
| +159% | +$201K |
|
3458
Global X US Infrastructure Development ETF
PAVE
$13.9B
| $299K | ﹤0.01% |
+11,937
| New | +$275K |
|
3459
CALL
Emerson Electric
EMR
$83.9B
| $298K | ﹤0.01% |
3,300
-10,600
| -76% | -$912K |
|
3460
First Majestic Silver
AG
$7.41B
| $297K | ﹤0.01% |
19,052
-26,504
| -58% | -$425K |
|
|
CALB
3461
DELISTED
California BanCorp Common Stock
CALB
| $297K | ﹤0.01% |
16,647
+3,515
| +27% | +$56.6K |
|
3462
Bridgewater Bancshares
BWB
$571M
| $295K | ﹤0.01% |
18,250
+8,502
| +87% | +$126K |
|
3463
Invesco WilderHill Clean Energy ETF
PBW
$407M
| $295K | ﹤0.01% |
+3,000
| New | +$343K |
|
3464
Tejon Ranch
TRC
$457M
| $295K | ﹤0.01% |
17,645
+10,887
| +161% | +$179K |
|
3465
Viemed Healthcare
VMD
$447M
| $295K | ﹤0.01% |
29,183
+4,752
| +19% | +$44.7K |
|
|
BRT
3466
BRT Apartments
BRT
$281M
| $294K | ﹤0.01% |
17,436
+1,881
| +12% | +$30.7K |
|
3467
Metropolitan Bank Holding Corp
MCB
$1.15B
| $294K | ﹤0.01% |
5,852
+3,593
| +159% | +$166K |
|
3468
PUT
Vanguard Real Estate ETF
VNQ
$39.2B
| $294K | ﹤0.01% |
3,200
-4,000
| -56% | -$352K |
|
|
AMNB
3469
DELISTED
American National Bankshares Inc
AMNB
| $294K | ﹤0.01% |
8,903
+632
| +8% | +$19.5K |
|
3470
iShares S&P India Nifty 50 Index Fund
INDY
$562M
| $292K | ﹤0.01% |
6,517
+2,767
| +74% | +$124K |
|
3471
ENI
E
$80.5B
| $291K | ﹤0.01% |
11,796
-484
| -4% | -$10.9K |
|
|
MTEM
3472
DELISTED
Molecular Templates, Inc.
MTEM
| $291K | ﹤0.01% |
1,541
+971
| +170% | +$170K |
|
3473
CALL
Dillards
DDS
$9.19B
| $290K | ﹤0.01% |
3,000
-12,800
| -81% | -$1.04M |
|
3474
iRadimed
IRMD
$1.16B
| $290K | ﹤0.01% |
11,301
+1,641
| +17% | +$39.2K |
|
3475
PUT
Signet Jewelers
SIG
$3.61B
| $290K | ﹤0.01% |
5,000
-26,000
| -84% | -$1.22M |
|
Similar funds
Barclays's Q1 2021 Portfolio in Review
As of Q1 2021, Barclays held 5,437 positions worth $186B, down 1.6% from $189B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays withdrew a net $12.6B in Q1 2021, closing 755 positions and reducing 1,271 holdings. Its most notable exit was Stellantis, an estimated $264M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.6% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in Ferguson worth $253M.
- Barclays's largest Q1 2021 buy was Ferguson: 2,109,370 shares worth $253M.
- Barclays added most to Apple in Q1 2021, an estimated $1.24B increase.
- Barclays's biggest Q1 2021 reduction was iShares US Real Estate ETF, cutting an estimated $1.14B.
- Barclays fully exited Stellantis in Q1 2021, selling an estimated $264M.
- Barclays's ten largest holdings make up 37% of its $186B portfolio in Q1 2021.
- Barclays opened 555 new positions and closed 755 in Q1 2021.
- Barclays's portfolio value fell 1.6% quarter-over-quarter to $186B.
Based on Barclays's 13F filing for Q1 2021, filed 13 May 2021.